President Donald Trump has directed the Centers for Medicare and Medicaid Services to terminate federal funding for gender-affirming medical treatments for minors. This policy change, which takes effect on October 13, removes coverage for surgeries, hormones, and puberty blockers under Medicaid and the Children's Health Insurance Program (CHIP).
The October 13 Deadline for Medicaid Funding Cuts
President Donald Trump revealed on Tuesday that he has instructed Dr. Mehmet Oz, the administrator of the Centers for Medicare and Medicaid Services, to implement a ban on federal funding for gender-transition procedures for youth. According to the report, the administration views these medical practices as causing "irreversible harm" to children, with the president describing the procedures as "barbaric."
The new rule specifically targets federal Medicaid and CHIP funds, meaning that the government will no longer pay for puberty blockers, hormone therapies ,or gender-affirming surgeries for minors. While federal support is being withdrawn, the report notes that individual state funds may still be utilized to cover these treatments, creating a fragmented landscape of care across the United States.
The 0.1 Percent Reality in JAMA Pediatrics
The administration's rhetoric regarding the prevalence of these procedures contrasts with recent medical data. A study published in JAMA Pediatrics analyzed an insurance claims database of over five million patients aged eight to 17 and found that fewer than 0.1 percent of all youth received these treatments. Specifically, between 2018 and 2022, only 926 adolescents received puberty blockers and 1,927 received hormones.
Landon Hughes, a public health researcher at Harvard University and author of the study, stated that the data suggests there is no "inappropriate use" of this care. As the report highlights, Hughes argued that the actual number of minors accessing these services is far lower than public perception suggests, suggesting the medical community is not seeing a surge in these procedures.
KFF's Report on 27 States with Existing Restrictions
This federal move follows a broader trend of state-level prohibitions on gender-affirming care. According to the health policy organization KFF, at least 27 states have already implemented their own restrictions on such treatments for children. The federal cut effectively aligns Medicaid funding with the legislative trajectory of these conservative-led states .
By removing federal subsidies, the Trump administration is leveraging the financial structure of Medicaid to enforce a national standard that mirrors these state laws. This shift places the financial burden of care entirely on private insurance or state-specific budgets, potentially pricing out low-income families who rely on federal assistance.
Kelley Robinson and the HRC's Fight Against 'Terrorizing' Policies
The Human Rights Campaign (HRC), the largest LGBTQ+ civil rights organization in the U.S., has condemned the move. HRC President Kelley Robinson stated that the Trump administration is "terrorizing trans youth and their families," arguing that medical decisions should remain between parents, providers, and patients rather than being dictated by politicians.
Despite the administration's clarity on the funding cut, several critical points remain unverified. It is currently unclear which specific states will choose to use their own funds to bridge the gap left by the loss of Medicaid and CHIP support. Furthermore, the report does not specify how the Centers for Medicare and Medicaid Services will handle patients currently in the middle of multi-year treatment protocols when the October 13 deadline arrives.
Comments 0